menu
    • menu

    Company profile for Olon S.p.A

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records. We rely on synthetic and biological processes both for generic a...
    We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records. We rely on synthetic and biological processes both for generic and contract development and the manufacturing market, in a full cGMPs environment, following ICH Q7 compliance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Olon S.p.AItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Societa con Socio unico, Strada Rivoltana km 6/7, 20090 Rodano (Milano)
    Telephone
    Telephone
    +39 02 95 231
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://olonspa.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/olon-spa
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    This week, SpeakPharma interviews Miquel Bachs, CEO of Inke, a company with over two decades of expertise in micronization and particle engineering, and a leader in providing high-quality, effective solutions in the global fight against chronic respiratory diseases such as COPD and asthma. In this insightful conversation, Bachs shares Inke’s strategic vision, technological innovations, and commitment to sustainability, offering a comprehensive look at how the company is shaping the future of respiratory health. HIGHLIGHTS// Inke’s strategic vision/ technological innovations/ commitment to sustainability Studies suggest that 13 percent of people over 40 years of age, the world over, have chronic obstructive pulmonary disease (COPD). Given the increasing prevalence of respiratory diseases, how does Inke position itself as a leader in the development and manufacturing of respiratory APIs? Inke has established itself as a global leader in generic respiratory API development through our unique blend  of technological innovation, expertise in micronization, and a comprehensive portfolio of inhalation therapies. With over 20 years of experience in micronization and particle engineering, our ability to customize APIs to meet specific client requirements has resulted in highly effective, high-quality products tailored for respiratory therapies. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has only underscored Inke’s pivotal role in supporting the pharmaceutical industry’s need for advanced treatments. We specialize in bronchodilators and other critical respiratory APIs that improve patient outcomes and meet the stringent regulatory requirements of global health authorities. Our end-to-end approach, from early-stage API development to commercial-scale production, ensures that we maintain the highest standards of quality, safety, and efficacy. As the market for respiratory APIs continues to evolve, Inke remains committed to expanding its portfolio to address unmet therapeutic needs. Beyond respiratory APIs, we are also prioritizing growth in CNS treatments and building on our expertise in complex molecule synthesis. This strategic focus allows us to provide an integrated solution that not only meets current market demands but also anticipates future pharmaceutical trends. HIGHLIGHTS// comprehensive portfolio of inhalation therapies/ over 20 years of experience in micronization and particle engineering/ specialize in bronchodilators and other critical respiratory APIs/ prioritizing growth in CNS treatments In the field of micronization, what differentiates Inke’s approach from that of other manufacturers of respiratory APIs? What sets Inke apart in micronization is our advanced particle size reduction technology and our dedication to precision. Our facility is equipped with various milling techniques such as Cone, Jet, and Pin mills, allowing us to reduce particle size while stabilizing the amorphous content to ensure consistent quality. Our in-depth understanding of respiratory APIs, combined with our ability to tailor solutions for each customer, results in APIs with improved solubility, stability, and bioavailability, which are critical for the efficacy of inhalation products. This, along with our exceptional quality standards and a flawless audit track record, has positioned us as a key partner for major players in the inhalation market. HIGHLIGHTS// advanced particle size reduction technology/ technological innovations/ tailor solutions/ improved solubility, stability, and bioavailability Developing complex APIs can be challenging. How does Inke ensure a smooth and successful partnership throughout the development and manufacturing process, including customization, ensuring regulatory compliance and timely delivery? At Inke, we are dedicated to fostering strong partnerships with our clients through a collaborative approach that prioritizes open communication and mutual understanding. Our commitment to quality and personalized service sets us apart in the pharmaceutical landscape. Our team takes the time to engage in comprehensive discussions to customize our solutions, ensuring alignment with client specifications across all batches and grades. This commitment to flexibility allows us to respond effectively to evolving requirements, solidifying Inke’s reputation as a reliable partner. We understand that navigating regulatory landscapes can be challenging. That's why our team is equipped to manage all aspects of the regulatory process with meticulous attention to detail. From the submission of Drug Master Files (DMFs) and Certificates of Suitability to crafting precise responses to potential Deficiency Letters, we ensure compliance at every step. Moreover, we offer extensive support in patent and intellectual property matters, providing technical assistance and guidance tailored to the specific requirements of each region. Our unwavering dedication to quality, coupled with our agile response capabilities, enables us to deliver exceptional results while maintaining transparency and trust. At Inke, we are committed to building lasting relationships that drive success for both our clients and our organization. HIGHLIGHTS// ensuring alignment with client specifications/ manage all aspects of the regulatory process/ support in patent and intellectual property matters Given Inke’s global presence, what are the key markets for growth and how does Inke plan to expand its market reach and strengthen its position in these regions? Inke is strategically focused on expanding its footprint in the European and US markets, where we continue to prioritize our efforts. The US market remains pivotal for us, especially considering our successful FDA inspections and ongoing regulatory compliance efforts that solidify our reputation. Japan is another significant market where we have established a robust presence, reflecting our commitment to high-quality manufacturing and innovation. Looking ahead, China represents a key growth opportunity for Inke. With 12 active DMFs registered, we are well-positioned to tap into this burgeoning market. Our strategy involves leveraging our existing capabilities to navigate regulatory landscapes and fostering strong partnerships within the region, thereby enhancing our market reach and influence in the pharmaceutical sector. HIGHLIGHTS// expanding footprint in the European and US markets/ China represents a key growth opportunity for Inke With Inke expanding into contract manufacturing organization (CMO) services, how does this new offering align with Inke’s broader strategic goals, and what advantages does it provide to pharmaceutical partners? At Inke, the introduction of CMO services is a natural extension of our core expertise in the development and manufacturing of high-quality generic APIs. Our expansion into CMO is part of a strategic move to diversify our service portfolio, allowing us to offer end-to-end solutions for our clients. The CMO service integrates seamlessly with our expertise in API manufacturing, particularly in micronization, which has been a key differentiator for Inke for over two decades. With our advanced particle engineering capabilities, we can offer tailored solutions that meet specific technical and regulatory requirements. Whether it is small-batch production or scaling up to commercial quantities, we offer the flexibility to accommodate a wide range of customer needs. This adaptability, paired with our deep expertise in micronization, allows us to support evolving project needs, maintaining the highest standards of consistency, quality, and performance that define Inke’s footprint. HIGHLIGHTS// CMO is part of a strategic move to diversify our service portfolio/ deep expertise in micronization What is Inke’s commitment to sustainability and corporate social responsibility and how is it integrating sustainable practices into its operations and product development? At Inke, we recognize that integrating environmental, social, and governance (ESG) principles into our operations is not just a responsibility but a pathway to long-term success. Our ESG vision is centered around aligning business growth with sustainable practices that positively impact our communities and the environment. We are dedicated to environmental responsibility, actively implementing initiatives such as efficient wastewater treatment and water reuse systems to minimize our ecological footprint. Our recent investments in energy efficiency include the installation of a 135 kWp solar panel system, which underscores our commitment to reducing emissions and resource consumption across our manufacturing and research facilities. Inke is also committed to fostering a diverse and inclusive workforce. With a notable increase in our team members, particularly in operations and quality assurance, we prioritize career development and the well-being of our employees. By adhering to high regulatory standards, we ensure our products meet stringent global requirements, enhancing our transparency and compliance. Through these initiatives, Inke aims to cultivate sustainable practices that not only support our business objectives but also contribute positively to the pharmaceutical industry and society at large. HIGHLIGHTS// integrating ESG principles/ efficient wastewater treatment and water reuse systems/ installation of a 135 kWp solar panel system/ diverse and inclusive workforce

    Impressions: 430

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

    #SpeakPharma With Inke
    28 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2489

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

    #PharmaFlow by PHARMACOMPASS
    24 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Olon Continues its Growth Path and Announces a New Acquisition
    Olon Continues its Growth Path and Announces a New Acquisition

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940274/0/en/Olon-Continues-its-Growth-Path-and-Announces-a-New-Acquisition.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Olon Group Announces the Acquisition of GTP Bioways Group
    Olon Group Announces the Acquisition of GTP Bioways Group

    03 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/03/2907981/0/en/Olon-Group-Announces-the-Acquisition-of-GTP-Bioways-Group.html

    GLOBENEWSWIRE
    03 Jul 2024
    Share Share
    Olon Group Signs
    Olon Group Signs "Businesses For People And Society" Manifesto

    26 Jun 2024

    // PRESS RELEASE

    https://olonspa.com/news/olon-group-is-among-the-signators-of-the-manifesto-businesses-for-people-and-society/

    PRESS RELEASE
    26 Jun 2024
    Share Share
    Olon Strategies for Right First Time Scale Up
    Olon Strategies for Right First Time Scale Up

    25 Jun 2024

    // PRESS RELEASE

    https://olonspa.com/news/focus/olon-strategies-for-right-first-time-scale-up/

    PRESS RELEASE
    25 Jun 2024
    Share Share
    Olon & Chromologics partnership
    Olon & Chromologics partnership

    28 May 2024

    // PRESS RELEASE

    https://olonspa.com/news/olon-chromologics-partnership/

    PRESS RELEASE
    28 May 2024
    Share Share
    Olon Enhances Therapeutic Peptide Production With Recombinant DNA Tech
    Olon Enhances Therapeutic Peptide Production With Recombinant DNA Tech

    20 May 2024

    // PRESS RELEASE

    https://olonspa.com/news/focus/recombinant-dna-technology-and-chimeric-protein-expression-to-enhance-the-production-of-therapeutic-peptides-in-microbial-systems/

    PRESS RELEASE
    20 May 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    7 Amino Cephalosporanic Acid

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    02

    Abacavir Sulfate

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    03

    Abiraterone Acetate

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    04

    Acamprosate Calcium

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    05

    Acamprosate Calcium

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    06

    Aceclidine Hydrochloride

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    07

    Acitretin

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    Acitretin

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Olon S.p.A

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-03-24

    Pay. Date : 2017-03-14

    DMF Number : 17001

    Submission : 2003-12-01

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Acitretin (form I)

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    09

    Acyclovir

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow

    Acyclovir

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Olon S.p.A

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-03-03

    Pay. Date : 2014-04-22

    DMF Number : 10685

    Submission : 1994-01-12

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Acyclovir

    Italy
    SupplySide West 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Acamprosate calcium

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    02

    Aciclovir

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    03

    Aciclovir

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    04

    Acitretin

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    05

    Adapalene

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    06

    Ambroxol hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    07

    Amiloride hydrochloride dihydrate

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    08

    Amiodarone hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    09

    Amitriptyline hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    10

    Amorolfine hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Fidia FDA Orphan Drug Designation for ONCOFID®-P for Malignant Mesothelioma

    Details:

    ONCOFID®-P is an anticancer drug in advanced clinical development for the loco-regional treatment of non-muscle invasive bladder cancer, on which it has already demonstrated potent efficacy and excellent tolerability.


    Lead Product(s): Paclitaxel

    Therapeutic Area: Oncology Brand Name: Oncofid-P

    Study Phase: Phase IIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 26, 2021

    blank

    01

    Fidia Farmaceutici Spa

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed

    Fidia Farmaceutici Spa

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Paclitaxel

    Therapeutic Area : Oncology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Fidia FDA Orphan Drug Designation for ONCOFID®-P for Malignant Mesothelioma

    Details : ONCOFID®-P is an anticancer drug in advanced clinical development for the loco-regional treatment of non-muscle invasive bladder cancer, on which it has already demonstrated potent efficacy and excellent tolerability.

    Brand Name : Oncofid-P

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    July 26, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Sanofi Continues Streamlining of Established Products with Sale of Anti-Inflammatory Drugs to Fidia Farmaceutici

    Details:

    The agreement covers the registrations, trademarks, and related commercial rights of seven products, including four corticosteroids and one non-steroidal anti-inflammatory drug, across Europe and Emerging Markets.


    Lead Product(s): Undisclosed

    Therapeutic Area: Immunology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Small molecule

    Recipient: Sanofi

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Divestment March 23, 2021

    blank

    02

    Fidia Farmaceutici Spa

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed

    Fidia Farmaceutici Spa

    Italy
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Immunology

    Highest Development Status : Undisclosed

    Recipient : Sanofi

    Deal Size : Undisclosed

    Deal Type : Divestment

    DEALS_DEV arrow-down

    Sanofi Continues Streamlining of Established Products with Sale of Anti-Inflammatory Drugs to Fidi...

    Details : The agreement covers the registrations, trademarks, and related commercial rights of seven products, including four corticosteroids and one non-steroidal anti-inflammatory drug, across Europe and Emerging Markets.

    Brand Name : Undisclosed

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    March 23, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Chiral Synthesis

    read-more
    read-more

    01

    SYNTHESIS OF ENANTIOPURE COMPOUN...

    SYNTHESIS OF ENANTIOPURE COMPOUNDS

    arrow
    SupplySide West 2024
    Not Confirmed
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    Olon S.p.A

    City : Settimo Torinese

    State :

    Country/Area : IT

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-06-14

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-15

    Derivados Quimicos SAU

    City : Alcantarilla

    State :

    Country/Area : ES

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-06-18

    Olon Ricerca Bioscience

    City : Painesville

    State : OH

    Country/Area : US

    Zip : 44077-9176

    District : CIN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-06-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2012-02-16

    Olon Ricerca Bioscience

    City : Painesville

    State : OH

    Country/Area : US

    Zip : 44077-9176

    District : CIN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2012-02-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-29

    Olon Ricerca Bioscience

    City : Painesville

    State : OH

    Country/Area : US

    Zip : 44077-9176

    District : CIN

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-05-29

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    AusBiotech 2024
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    AusBiotech 2024
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-07-01

    Fidia Pharma USA Inc

    City : Parsippany

    State : NJ

    Country/Area : US

    Zip : 07054-1100

    District : NWJ

    Center : CDRH

    Project Area : Compliance: Devices

    District Decision : No Action Indicated

    Inspection End Date : 2014-07-01

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Olon S.p.A and get a quotation

    Olon S.p.A is a supplier offers 278 products (APIs, Excipients or Intermediates).

    Find a price of Quetiapine Hemifumarate bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Rifaximin bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Aciclovir bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Adapalene bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Bezafibrate bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Bumetanide bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Doxorubicin Hydrochloride bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Hydroxyurea bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Raloxifene Hydrochloride bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Tretinoin bulk with DMF, CEP, JDMF offered by Olon S.p.A

    Find a price of Aripiprazole bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Rifampicin bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Acamprosate Calcium bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Acitretin bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Alpha Lipoic Acid bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Bendamustine Hydrochloride bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Benzhexol hydrochloride bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Bicalutamide bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Cefazolin bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Cefazolin Sodium bulk with CEP, JDMF offered by Olon S.p.A

    Find a price of Daunorubicin HCl bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Epirubicin Hydrochloride bulk with CEP, JDMF offered by Olon S.p.A

    Find a price of Fenofibrate bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Glycopyrronium Bromide bulk with CEP, JDMF offered by Olon S.p.A

    Find a price of Hydroxyurea bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Irinotecan Hydrochloride bulk with DMF, JDMF offered by Olon S.p.A

    Find a price of Isotretinoin bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Loperamide Hydrochloride bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Miconazole bulk with CEP, JDMF offered by Olon S.p.A

    Find a price of Minoxidil bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Moxifloxacin Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Nystatin bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Pergolide Mesylate bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Pramipexole Dihydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Tamoxifen Citrate bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Terbinafine Hydrochloride bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Tretinoin bulk with DMF, CEP offered by Olon S.p.A

    Find a price of Aprepitant bulk with DMF offered by Olon S.p.A

    Find a price of Escitalopram Oxalate bulk with CEP offered by Olon S.p.A

    Find a price of Lansoprazole bulk with CEP offered by Olon S.p.A

    Find a price of Metformin bulk with DMF offered by Olon S.p.A

    Find a price of Posaconazole bulk with DMF offered by Olon S.p.A

    Find a price of Rotigotine bulk with CEP offered by Olon S.p.A

    Find a price of Tigecycline bulk with DMF offered by Olon S.p.A

    Find a price of 7-Amino Cephalosporanic Acid bulk with DMF offered by Olon S.p.A

    Find a price of Abacavir Sulfate bulk with DMF offered by Olon S.p.A

    Find a price of Abiraterone Acetate bulk with DMF offered by Olon S.p.A

    Find a price of Acamprosate Calcium bulk with DMF offered by Olon S.p.A

    Find a price of Aceclidine Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Acitretin bulk with DMF offered by Olon S.p.A

    Find a price of Alitretinoin bulk with DMF offered by Olon S.p.A

    Find a price of Alpha Lipoic Acid bulk with CEP offered by Olon S.p.A

    Find a price of Amiloride Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Amiodarone Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Amitriptyline Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Amorolfine Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Asenapine Maleate bulk with DMF offered by Olon S.p.A

    Find a price of Atazanavir Sulfate bulk with DMF offered by Olon S.p.A

    Find a price of Benzhexol hydrochloride bulk with JDMF offered by Olon S.p.A

    Find a price of Benzphetamine bulk with DMF offered by Olon S.p.A

    Find a price of Betahistine Dihydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Betaxolol bulk with CEP offered by Olon S.p.A

    Find a price of Bezafibrate bulk with CEP offered by Olon S.p.A

    Find a price of Bromperidol bulk with CEP offered by Olon S.p.A

    Find a price of Bromperidol Decanoate bulk with CEP offered by Olon S.p.A

    Find a price of Bupropion Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Cangrelor bulk with DMF offered by Olon S.p.A

    Find a price of Cefdinir bulk with DMF offered by Olon S.p.A

    Find a price of Choline Fenofibrate bulk with DMF offered by Olon S.p.A

    Find a price of Ciclopirox bulk with CEP offered by Olon S.p.A

    Find a price of Ciclopirox Olamine bulk with CEP offered by Olon S.p.A

    Find a price of Clidinium bulk with DMF offered by Olon S.p.A

    Find a price of Clofarabine bulk with DMF offered by Olon S.p.A

    Find a price of Clofazimine bulk with DMF offered by Olon S.p.A

    Find a price of Clotrimazole bulk with CEP offered by Olon S.p.A

    Find a price of Crisaborole bulk with DMF offered by Olon S.p.A

    Find a price of Cyproheptadine Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Daptomycin bulk with DMF offered by Olon S.p.A

    Find a price of Daunorubicin HCl bulk with JDMF offered by Olon S.p.A

    Find a price of Deacetyl-7-Aminocephalosporanic Acid bulk with DMF offered by Olon S.p.A

    Find a price of Dequalinium Chloride bulk with JDMF offered by Olon S.p.A

    Find a price of Diclofenac Potassium bulk with CEP offered by Olon S.p.A

    Find a price of Diclofenac Sodium bulk with CEP offered by Olon S.p.A

    Find a price of Dicyclomine Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Diethylpropion Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Dihydroergotamine Mesylate bulk with DMF offered by Olon S.p.A

    Find a price of Dimetindene bulk with CEP offered by Olon S.p.A

    Find a price of Doxepin Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Fenfluramine Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Fenofibrate bulk with CEP offered by Olon S.p.A

    Find a price of Fenretinide bulk with DMF offered by Olon S.p.A

    Find a price of Flunarizine bulk with CEP offered by Olon S.p.A

    Find a price of Fluspirilene bulk with CEP offered by Olon S.p.A

    Find a price of Furosemide bulk offered by Olon S.p.A

    Find a price of Gabapentin bulk with CEP offered by Olon S.p.A

    Find a price of Gliclazide bulk with CEP offered by Olon S.p.A

    Find a price of Glipizide bulk with DMF offered by Olon S.p.A

    Find a price of Ipratropium Bromide bulk with CEP offered by Olon S.p.A

    Find a price of Ketotifen Fumarate bulk with CEP offered by Olon S.p.A

    Find a price of Labetalol Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Larotrectinib Sulfate bulk with DMF offered by Olon S.p.A

    Find a price of Lenvatinib Mesylate bulk with DMF offered by Olon S.p.A

    Find a price of Lifitegrast bulk with DMF offered by Olon S.p.A

    Find a price of Loperamide Hydrochloride bulk with CEP offered by Olon S.p.A

    Find a price of Lymecycline bulk with CEP offered by Olon S.p.A

    Find a price of MAPROTILINE HYDROCHLORIDE bulk with CEP offered by Olon S.p.A

    Find a price of Mefloquine bulk with CEP offered by Olon S.p.A

    Find a price of Melphalan Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Memantine Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Miconazole Nitrate bulk with CEP offered by Olon S.p.A

    Find a price of Mycophenolic Acid bulk with DMF offered by Olon S.p.A

    Find a price of Nicergoline bulk with JDMF offered by Olon S.p.A

    Find a price of Niclosamide bulk with DMF offered by Olon S.p.A

    Find a price of Nintedanib Esylate bulk with DMF offered by Olon S.p.A

    Find a price of Nortriptyline bulk with CEP offered by Olon S.p.A

    Find a price of Olaparib bulk with DMF offered by Olon S.p.A

    Find a price of Ospemifene bulk with DMF offered by Olon S.p.A

    Find a price of Otilonium Bromide bulk with DMF offered by Olon S.p.A

    Find a price of Oxaprozin bulk with DMF offered by Olon S.p.A

    Find a price of Paromomycin bulk with DMF offered by Olon S.p.A

    Find a price of Paromomycin Sulfate bulk with JDMF offered by Olon S.p.A

    Find a price of Phendimetrazine Tartrate bulk with DMF offered by Olon S.p.A

    Find a price of Phentermine Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Pimozide bulk with CEP offered by Olon S.p.A

    Find a price of Pipamperone bulk with JDMF offered by Olon S.p.A

    Find a price of Piroxicam bulk with CEP offered by Olon S.p.A

    Find a price of Pomalidomide bulk with DMF offered by Olon S.p.A

    Find a price of Pralsetinib bulk with DMF offered by Olon S.p.A

    Find a price of Rifabutin bulk with DMF offered by Olon S.p.A

    Find a price of Rifampicin bulk with DMF offered by Olon S.p.A

    Find a price of Rifamycin bulk with DMF offered by Olon S.p.A

    Find a price of Rifamycin Sodium bulk with DMF offered by Olon S.p.A

    Find a price of Ritonavir bulk with DMF offered by Olon S.p.A

    Find a price of Rotigotine bulk with DMF offered by Olon S.p.A

    Find a price of Silodosin bulk with DMF offered by Olon S.p.A

    Find a price of Sodium Cromoglicate bulk with CEP offered by Olon S.p.A

    Find a price of Tazarotene bulk with DMF offered by Olon S.p.A

    Find a price of Teniposide bulk with DMF offered by Olon S.p.A

    Find a price of Terbinafine bulk with DMF offered by Olon S.p.A

    Find a price of Teriflunomide bulk with DMF offered by Olon S.p.A

    Find a price of Thalidomide bulk with DMF offered by Olon S.p.A

    Find a price of Timolol Maleate bulk with CEP offered by Olon S.p.A

    Find a price of Tofacitinib Citrate bulk with DMF offered by Olon S.p.A

    Find a price of Tolvaptan bulk with DMF offered by Olon S.p.A

    Find a price of Toremifene Citrate bulk with DMF offered by Olon S.p.A

    Find a price of Trifarotene bulk with DMF offered by Olon S.p.A

    Find a price of Trilaciclib Dihydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Trospium Chloride bulk with CEP offered by Olon S.p.A

    Find a price of Umeclidinium Bromide bulk with DMF offered by Olon S.p.A

    Find a price of Valganciclovir Hydrochloride bulk with DMF offered by Olon S.p.A

    Find a price of Zanubrutinib bulk with DMF offered by Olon S.p.A

    Find a price of ONCOFID-P20 bulk with DMF offered by Olon S.p.A

    Find a price of Ambroxol Hydrochloride bulk offered by Olon S.p.A

    Find a price of Atomoxetin Hydrochloride bulk offered by Olon S.p.A

    Find a price of Balsalazide Disodium bulk offered by Olon S.p.A

    Find a price of Cefuroxime Axetil bulk offered by Olon S.p.A

    Find a price of Clopidogrel Hydrochloride bulk offered by Olon S.p.A

    Find a price of Dienogest bulk offered by Olon S.p.A

    Find a price of Duloxetine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Famciclovir bulk offered by Olon S.p.A

    Find a price of Gemcitabine bulk offered by Olon S.p.A

    Find a price of Lactobionic Acid bulk offered by Olon S.p.A

    Find a price of Letrozole bulk offered by Olon S.p.A

    Find a price of Mycophenolate Mofetil bulk offered by Olon S.p.A

    Find a price of Mycophenolic Acid bulk offered by Olon S.p.A

    Find a price of Nizatidine bulk offered by Olon S.p.A

    Find a price of Omega-3-Acid Ethyl Esters 90 bulk offered by Olon S.p.A

    Find a price of Oxandrolone bulk offered by Olon S.p.A

    Find a price of Pentazocine bulk offered by Olon S.p.A

    Find a price of Sibutramine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Spironolactone bulk offered by Olon S.p.A

    Find a price of Tamoxifen Citrate bulk offered by Olon S.p.A

    Find a price of Valacyclovir Hydrochloride bulk offered by Olon S.p.A

    Find a price of Venlafaxine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Acebrophylline bulk offered by Olon S.p.A

    Find a price of Acipimox bulk offered by Olon S.p.A

    Find a price of Aclidinium Bromide bulk offered by Olon S.p.A

    Find a price of Aldoxorubicin HCl bulk offered by Olon S.p.A

    Find a price of Alogliptin Benzoate bulk offered by Olon S.p.A

    Find a price of Alpha-Glucose-1-Phosphate Disodium bulk offered by Olon S.p.A

    Find a price of Althiazide bulk offered by Olon S.p.A

    Find a price of Apalutamide bulk offered by Olon S.p.A

    Find a price of Azacitidine bulk offered by Olon S.p.A

    Find a price of Barnidipine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Benperidol bulk offered by Olon S.p.A

    Find a price of Bexarotene bulk offered by Olon S.p.A

    Find a price of Blonanserin bulk offered by Olon S.p.A

    Find a price of Bosentan Hydrate bulk offered by Olon S.p.A

    Find a price of Bufexamac bulk offered by Olon S.p.A

    Find a price of Butamirate Citrate bulk offered by Olon S.p.A

    Find a price of Butoconazole Nitrate bulk offered by Olon S.p.A

    Find a price of Carisoprodol bulk offered by Olon S.p.A

    Find a price of Cefdinir Monohydrate bulk offered by Olon S.p.A

    Find a price of Chlorcyclizine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Cicletanine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Ciprofibrate bulk offered by Olon S.p.A

    Find a price of Clobenzorex Hydrochloride bulk offered by Olon S.p.A

    Find a price of Clodronic Acid Disodium Salt bulk offered by Olon S.p.A

    Find a price of Cloricromen Hydrochloride bulk offered by Olon S.p.A

    Find a price of Cyclobenzaprine bulk offered by Olon S.p.A

    Find a price of Dantrolene bulk offered by Olon S.p.A

    Find a price of Dapoxetine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Decitabine bulk offered by Olon S.p.A

    Find a price of Deferoxamine Mesylate bulk offered by Olon S.p.A

    Find a price of Diclofenac Diethylamine bulk offered by Olon S.p.A

    Find a price of Domperidone bulk offered by Olon S.p.A

    Find a price of Econazole Nitrate bulk offered by Olon S.p.A

    Find a price of Efinaconazole bulk offered by Olon S.p.A

    Find a price of Elagolix Sodium bulk offered by Olon S.p.A

    Find a price of Enzalutamide bulk offered by Olon S.p.A

    Find a price of Epinephrine bulk offered by Olon S.p.A

    Find a price of Ergotamine bulk offered by Olon S.p.A

    Find a price of Ethacrynic Acid bulk offered by Olon S.p.A

    Find a price of Etofamide bulk offered by Olon S.p.A

    Find a price of Etretinate bulk offered by Olon S.p.A

    Find a price of Fenofibrate bulk offered by Olon S.p.A

    Find a price of Fidaxomicin bulk offered by Olon S.p.A

    Find a price of Flupentixol Decanoate bulk offered by Olon S.p.A

    Find a price of Flupentixol Dihydrochloride bulk offered by Olon S.p.A

    Find a price of Flutamide bulk offered by Olon S.p.A

    Find a price of Fluvoxamine bulk offered by Olon S.p.A

    Find a price of Haloperidol bulk offered by Olon S.p.A

    Find a price of Haloperidol Decanoate bulk offered by Olon S.p.A

    Find a price of Ibuprofen Lysinate bulk offered by Olon S.p.A

    Find a price of Ibuprofen Sodium bulk offered by Olon S.p.A

    Find a price of Idarubicin Hydrochloride bulk offered by Olon S.p.A

    Find a price of Indacaterol Maleate bulk offered by Olon S.p.A

    Find a price of Indobufen bulk offered by Olon S.p.A

    Find a price of Isoproterenol Hydrochloride bulk offered by Olon S.p.A

    Find a price of Ivabradine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Ketoconazole bulk offered by Olon S.p.A

    Find a price of Lasmiditan bulk offered by Olon S.p.A

    Find a price of Lefamulin Acetate bulk offered by Olon S.p.A

    Find a price of Letermovir bulk offered by Olon S.p.A

    Find a price of Levalbuterol Hydrochloride bulk offered by Olon S.p.A

    Find a price of Levobunolol bulk offered by Olon S.p.A

    Find a price of Levosimendan bulk offered by Olon S.p.A

    Find a price of Lomifylline bulk offered by Olon S.p.A

    Find a price of Lurasidone Hydrochloride bulk offered by Olon S.p.A

    Find a price of Meloxicam bulk offered by Olon S.p.A

    Find a price of Melperone bulk offered by Olon S.p.A

    Find a price of Metergoline bulk offered by Olon S.p.A

    Find a price of Milnacipran HCl bulk offered by Olon S.p.A

    Find a price of Milnacipran Hydrochloride bulk offered by Olon S.p.A

    Find a price of Nafronyl Oxalate bulk offered by Olon S.p.A

    Find a price of NAFTIFINE HCL bulk offered by Olon S.p.A

    Find a price of Nicardipine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Nimesulide bulk offered by Olon S.p.A

    Find a price of Nimorazole bulk offered by Olon S.p.A

    Find a price of Perhexiline Maleate bulk offered by Olon S.p.A

    Find a price of Pimavanserin Tartrate bulk offered by Olon S.p.A

    Find a price of Pinaverium Bromide bulk offered by Olon S.p.A

    Find a price of Piretanide bulk offered by Olon S.p.A

    Find a price of Pitavastatin bulk offered by Olon S.p.A

    Find a price of Pizotifen Malate bulk offered by Olon S.p.A

    Find a price of Prednisolone bulk offered by Olon S.p.A

    Find a price of Pregabalin bulk offered by Olon S.p.A

    Find a price of Pridinol bulk offered by Olon S.p.A

    Find a price of Procyclidine bulk offered by Olon S.p.A

    Find a price of Propentofylline bulk offered by Olon S.p.A

    Find a price of Protriptyline bulk offered by Olon S.p.A

    Find a price of Pyridoxine Hydrochloride bulk offered by Olon S.p.A

    Find a price of Soberol bulk offered by Olon S.p.A

    Find a price of Sulindac bulk offered by Olon S.p.A

    Find a price of Tavaborole bulk offered by Olon S.p.A

    Find a price of Teduglutide bulk offered by Olon S.p.A

    Find a price of Teicoplanin bulk offered by Olon S.p.A

    Find a price of Tenoxicam bulk offered by Olon S.p.A

    Find a price of Terconazole bulk offered by Olon S.p.A

    Find a price of Thiotepa bulk offered by Olon S.p.A

    Find a price of Tiotropium Bromide bulk offered by Olon S.p.A

    Find a price of Trichlormethiazide bulk offered by Olon S.p.A

    Find a price of Urapidil Hydrochloride bulk offered by Olon S.p.A

    Find a price of Venetoclax bulk offered by Olon S.p.A

    Find a price of Vilanterol Trifenatate bulk offered by Olon S.p.A

    Find a price of Virginiamycin bulk offered by Olon S.p.A

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search